Propranolol and nifedipine efficacy against hypertension

Juntao Shi

doi:10.1117/12.2669574

24 March 2023 Propranolol and nifedipine efficacy against hypertension

Juntao Shi

Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 1261163 (2023) https://doi.org/10.1117/12.2669574
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom

Abstract

The risk of cardiovascular diseases is increasing for all age groups, and hypertension is a leading risk factor. Noticeably, the proportion of middle-aged patients is increasing, which means the younger ages are being threatened. According to WHO, an estimated 46% of adults are unaware of their disease. Many drugs are being developed currently. This article mainly discussed two types-beta blockers and calcium channel blockers (CCB). Propranolol and nifedipine, as the most classical drugs in these two types, are elaborated, including their origins, structures, modes of action, synthesis, efficacy, contraindications, prices, and prescriptions. A comparison is being made on their similarities and differences.

Citation Download Citation

Juntao Shi "Propranolol and nifedipine efficacy against hypertension", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 1261163 (24 March 2023); https://doi.org/10.1117/12.2669574

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available